End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.05 USD | +1.00% | -.--% | -.--% |
Financials (USD)
Sales 2023 * | 20.4M | Sales 2024 * | - | Capitalization | 409K |
---|---|---|---|---|---|
Net income 2023 * | -3M | Net income 2024 * | - | EV / Sales 2023 * | 0.02 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 0% |
1 day | +1.00% |
Managers | Title | Age | Since |
---|---|---|---|
Yacov Geva
CEO | Chief Executive Officer | 73 | 14-10-02 |
Igor Bluvstein
DFI | Director of Finance/CFO | 44 | 22-07-30 |
Benny Tal
CTO | Chief Tech/Sci/R&D Officer | 54 | 17-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Yacov Geva
CEO | Chief Executive Officer | 73 | 14-10-02 |
Kenneth Melani
CHM | Chairman | 70 | 14-08-20 |
Director/Board Member | 74 | 17-02-23 |
Quarterly revenue - Rate of surprise
- Stock
- Equities
- Stock G MEDPAR
- Stock G Medical Innovations Holdings Ltd - OTC Markets